Cardisio

company

About

Cardisio is a company that uses artificial intelligence in a non-invasive screening test for coronary and structural heart diseases.

  • Frankfurt,Hessen,Germany
  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
€3.50M
Industries
Artificial Intelligence,Fitness,Health Care,Wellness
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Cardisio GmbH.

Cardisio is a mobile health tech company that uses artificial intelligence in a non-invasive screening test for coronary and structural heart diseases. The Cardisiography test can detect heart disease early, allowing for preventive treatment to avoid a potentially fatal heart attack. Cardisiography analyzes the individual three-dimensional electrophysical profile of the heart and recognizes pathological patterns of heart diseases using a proprietary algorithm and neural networks (AI). The test requires a PC to access the web service (Cardisio Cloud), a data collector (e.g. a Cardisiograph), and commercially available ECG cables as well as five disposable electrodes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€3.50M
Cardisio has raised a total of €3.50M in funding over 2 rounds. Their latest funding was raised on Oct 19, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 19, 2021 Seed €3.50M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Cardisio is funded by 2 investors. Jim Davidson and Shawn O'Neill are the most recent investors.
Investor Name Lead Investor Funding Round
Jim Davidson Seed
Shawn O'Neill Seed

Employee Profiles

Number of Employee Profiles
5
Cardisio has 5 current employee profiles, including Executive Thomas Fechner
Executive
Executive
Executive
Executive